{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:10:13Z","timestamp":1789938613451,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.biomaterials.2010.08.059","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T05:02:06Z","timestamp":1285650126000},"page":"9535-9543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengqun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2010.08.059_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/1871520610909040392","article-title":"The effects of cantharidin and cantharidin derivates on tumour cells","volume":"9","author":"Liu","year":"2009","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib2","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.bmcl.2004.01.093","article-title":"Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity","volume":"14","author":"Hart","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib3","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1073\/pnas.0905930106","article-title":"Inhibition of serine\/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms","volume":"106","author":"Lu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/era.09.184","article-title":"Do stem-like cells play a role in drug resistance of sarcomas?","volume":"10","author":"Honoki","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.surg.2008.04.008","article-title":"The search for cancer stem cells in hepatocellular carcinoma","volume":"144","author":"Kamohara","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11626-007-9056-y","article-title":"Spontaneous transformation of a clonal population of dermis-derived multipotent cells in culture","volume":"43","author":"Shi","year":"2007","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"Tolar","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","article-title":"Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation","volume":"24","author":"Miura","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib10","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.ejca.2007.10.021","article-title":"Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells","volume":"43","author":"Yamate","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/carcin\/bgn234","article-title":"Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds","volume":"30","author":"Tasso","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(09)70286-4","article-title":"Ewing\u2019s sarcoma","volume":"11","author":"Balamuth","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1586\/era.09.176","article-title":"Role of chemotherapy in the management of soft tissue sarcomas","volume":"10","author":"Krikelis","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/COC.0b013e318173a54f","article-title":"The management of adult soft tissue sarcomas","volume":"32","author":"Mendenhall","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1586\/era.09.64","article-title":"New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma","volume":"9","author":"Schmitt","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib16","doi-asserted-by":"crossref","first-page":"e1000733","DOI":"10.1371\/journal.ppat.1000733","article-title":"Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis","volume":"6","author":"Velupillai","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000074939","article-title":"Effects of acute wound environment on neonatal rat dermal multipotent cells","volume":"175","author":"Shi","year":"2003","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF02469570","article-title":"Colony growth of cells from primary breast carcinoma in soft agar culture","volume":"14","author":"Wada","year":"1984","journal-title":"Jpn J Surg"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib19","first-page":"221","article-title":"The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells","volume":"42","author":"Czeczuga-Semeniuk","year":"2004","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib20","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.2174\/092986709789909611","article-title":"Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment","volume":"16","author":"Liu","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib21","first-page":"1413","article-title":"Epigenetic remodelling of DNA in cancer","volume":"22","author":"Lettini","year":"2007","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2009.06.068","article-title":"Proteins selectively killing tumor cells","volume":"625","author":"Noteborn","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib23","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1242\/jcs.039719","article-title":"How do anti-mitotic drugs kill cancer cells?","volume":"122","author":"Gascoigne","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2407-9-196","article-title":"KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?","volume":"9","author":"Valensin","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib25","first-page":"1","article-title":"Protein phosphatase 2A regulatory subunits and cancer","volume":"1795","author":"Eichhorn","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2010.08.059_bib26","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.4161\/cc.8.20.9689","article-title":"Enhancement of cancer chemotherapy by simultaneously altering cell cycle progression and DNA-damage defenses through global modification of the serine\/threonine phospho-proteome","volume":"8","author":"Zhuang","year":"2009","journal-title":"Cell Cycle"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210010975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210010975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:23:23Z","timestamp":1758900203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961210010975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":26,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0142961210010975"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.08.059","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.08.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}